Aislamiento de ácidos nucleicos mediante la utilización de polidocanol y derivados del mismo
Composición que comprende: - un agente caotrópico,Composición que comprende: - un agente caotrópico, - una sustancia tamponadora, - una proteasa, y - - una sustancia tamponadora, - una proteasa, y - polidocanol al 0,5% a 4,9% (v/v) o un derivado delpolidocanol al 0,5% a 4,9% (v/v) o un derivado del...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Composición que comprende: - un agente caotrópico,Composición que comprende: - un agente caotrópico, - una sustancia tamponadora, - una proteasa, y - - una sustancia tamponadora, - una proteasa, y - polidocanol al 0,5% a 4,9% (v/v) o un derivado delpolidocanol al 0,5% a 4,9% (v/v) o un derivado del mismo. mismo.
This invention relates to a composition comprising a chaotropic agent, a buffering substance, and 0.5 to 5% (V/V) polidocanol or a derivative thereof. The invention is further related to uses of this composition and to a kit comprising the composition according to the invention. The invention is further related to a method for the detection of a nucleic acid in a biological sample comprising the steps of incubating the biological sample in the presence of a chaotropic agent, a buffering substance, and 0.5 to 5% (V/V) polidocanol or a derivative thereof, optionally isolating the nucleic acid, optionally amplifying the nucleic acid, and detecting the nucleic acid. The invention is further related to a method for the purification of a nucleic acid in a biological sample comprising the steps of incubating the biological sample in the presence of a chaotropic agent, a buffering substance, and 0.5 to 5% (V/V) polidocanol or a derivative thereof and isolating the nucleic acid thereby purifying the nucleic acid. |
---|